The study team examined links between three common gynecologic diagnoses—endometriosis, PCOS, and uterine fibroids—and adult-onset psychiatric conditions in female participants from the UK Biobank. Investigators reported that all three gynecologic disorders were associated with elevated risks of mood disorders and anxiety and stress-related disorders in matched-cohort analyses. Endometriosis additionally associated with behavioral syndromes that have physical components. The authors used multiple complementary analytic strategies to triangulate evidence across observational and genetic approaches.
Authors applied polygenic risk score (PRS) methods and bidirectional two-sample Mendelian randomization (MR) to probe genetic overlap and potential causal relationships. Data indicated shared genetic liability across some gynecologic and psychiatric phenotypes. The MR analyses, as reported in the abstract, supported shared liability and causal effects between uterine fibroids and anxiety disorders. The abstract does not provide detailed instrument strength metrics, variant lists, or sensitivity MR estimates; those elements may be in the full manuscript or supplementary material.
The preprint describes a matched-pair cohort design in UK Biobank female participants, coupled with a PRS-based cohort analysis and bidirectional two-sample MR. Authors performed sensitivity analyses to assess robustness of the findings. The abstract does not enumerate matching variables, exclusion criteria, age ranges, diagnostic coding definitions, or the specific PRS construction parameters; readers must consult the full text or supplementary files for analytic specifications. Data for the UK Biobank are available on application, and the authors state their usage occurred under license.
In the matched-cohort analyses that the authors reported, effect sizes varied by gynecologic condition and psychiatric outcome. Endometriosis showed an odds ratio of 1.51 for mood disorders and 1.49 for anxiety and stress-related disorders; behavioral syndromes with physical components carried a smaller increased odds (OR 1.28). Uterine fibroids associated with mood disorders (OR 1.17) and with anxiety and stress-related disorders (OR 1.40), and also with behavioral syndromes (OR 1.29). For PCOS, reported associations included mood disorders (OR 1.47) and anxiety and stress-related disorders (OR 1.79). The abstract provides 95% confidence intervals for each OR but does not report p-values or time-to-event metrics in the summary.
The study team observed no association between any of the three gynecologic disorders and schizophrenia or other psychotic disorders in the analyses reported. That null finding suggests some degree of specificity in the pattern of psychiatric risk—higher for mood and anxiety-spectrum diagnoses, absent for psychoses—within the sampled cohort and analytic approach.
Authors conclude that women with gynecologic disorders face increased risks of mood and anxiety- and stress-related disorders, with additional behavioral-syndrome risk for those with endometriosis or fibroids. They note that part of this risk appears genetically mediated. Based on those observations, the authors argue for routine mental health screening in gynecologic care and for integrated gynecologic-mental health treatment strategies. The abstract does not provide specific screening instruments, frequency recommendations, or protocolized referral pathways.
Ethical approval for UK Biobank data use is reported via the NHS National Research Ethics Service (16/NW/0274), and the authors state that all participants provided informed consent. Data are available from UK Biobank by application; the authors used data under license and therefore the analytic dataset is not publicly accessible without UK Biobank approval. Competing interest disclosures were provided: three authors declared no financial relationships relevant to the work; one author reported consulting and equity interests with industry.
This report is a preprint and has not been peer reviewed. The abstract notes sensitivity analyses but does not detail matching covariates, PRS construction parameters, or MR instrument specifics; those methodological details are not reported in the abstract and must be obtained from the full manuscript or supplementary files. The data derive from UK Biobank participants only, and the authors used licensed data; the generalizability to non-UK Biobank populations is therefore uncertain. Unanswered clinical questions remaining in the preprint include the optimal screening tools and integration pathways for mental health evaluation in gynecologic care, and the extent to which identified genetic liabilities translate into modifiable clinical interventions. The manuscript does not claim regulatory milestones; peer review and external replication were not reported in the abstract and remain outstanding.